IRIDEX Corp (IRIX)
1.76
-0.13
(-6.88%)
USD |
NASDAQ |
Nov 14, 16:00
1.76
0.00 (0.00%)
After-Hours: 20:00
IRIDEX Research and Development Expense (Quarterly): 1.501M for June 30, 2024
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 1.501M |
| March 31, 2024 | 1.536M |
| December 31, 2023 | 1.694M |
| September 30, 2023 | 1.541M |
| June 30, 2023 | 1.845M |
| March 31, 2023 | 1.749M |
| December 31, 2022 | 1.45M |
| September 30, 2022 | 1.687M |
| June 30, 2022 | 1.922M |
| March 31, 2022 | 2.116M |
| December 31, 2021 | 2.243M |
| September 30, 2021 | 1.788M |
| June 30, 2021 | 1.672M |
| March 31, 2021 | 1.165M |
| December 31, 2020 | 0.887M |
| September 30, 2020 | 0.869M |
| June 30, 2020 | 0.807M |
| March 31, 2020 | 0.719M |
| December 31, 2019 | 0.788M |
| September 30, 2019 | 1.007M |
| June 30, 2019 | 0.929M |
| March 31, 2019 | 0.958M |
| December 31, 2018 | 0.852M |
| September 30, 2018 | 1.149M |
| June 30, 2018 | 0.901M |
| Date | Value |
|---|---|
| March 31, 2018 | 1.104M |
| December 31, 2017 | 1.18M |
| September 30, 2017 | 1.32M |
| June 30, 2017 | 1.369M |
| March 31, 2017 | 1.339M |
| December 31, 2016 | 1.358M |
| September 30, 2016 | 1.256M |
| June 30, 2016 | 1.392M |
| March 31, 2016 | 1.359M |
| December 31, 2015 | 1.214M |
| September 30, 2015 | 1.237M |
| June 30, 2015 | 1.482M |
| March 31, 2015 | 1.281M |
| December 31, 2014 | 1.033M |
| September 30, 2014 | 1.096M |
| June 30, 2014 | 1.306M |
| March 31, 2014 | 1.194M |
| December 31, 2013 | 0.881M |
| September 30, 2013 | 0.923M |
| June 30, 2013 | 0.884M |
| March 31, 2013 | 0.996M |
| December 31, 2012 | 1.091M |
| September 30, 2012 | 1.006M |
| June 30, 2012 | 1.106M |
| March 31, 2012 | 1.182M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
0.719M
Minimum
Mar 2020
2.243M
Maximum
Dec 2021
1.473M
Average
1.541M
Median
Sep 2023
Research and Development Expense (Quarterly) Benchmarks
| Cutera Inc | 4.353M |
| Stereotaxis Inc | 2.273M |
| Electromed Inc | 0.176M |
| Axogen Inc | 6.996M |
| Myomo Inc | 1.249M |